Hepatitis Monthly

Published by: Kowsar

Introducing an Optimal Liver Allocation System for Liver Cirrhosis Patients

Jamileh Abolghasemi 1 , Mohammad Reza Eshraghian 1 , * , Mohsen Nasiri Toosi 2 , Mahmood Mahmoodi 1 and Abbas Rahimi Foroushani 1
Authors Information
1 Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran
2 Department of Gastroenterology, School of Medicine, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Hepatitis Monthly: August 01, 2013, 13 (8); e10479
  • Published Online: August 30, 2013
  • Article Type: Research Article
  • Received: January 29, 2013
  • Revised: February 8, 2013
  • Accepted: February 20, 2013
  • DOI: 10.5812/hepatmon.10479

To Cite: Abolghasemi J, Eshraghian M R, Nasiri Toosi M, Mahmoodi M, Rahimi Foroushani A. Introducing an Optimal Liver Allocation System for Liver Cirrhosis Patients, Hepat Mon. 2013 ; 13(8):e10479. doi: 10.5812/hepatmon.10479.

Copyright © 2013, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Ganji A, Malekzadeh F, Safavi M, Nassri-Moghaddam S, Nourie M, Merat S, et al. Digestive and liver disease statistics in Iran. Middle East J Dig Dis. 2009; 1(2): 56-62
  • 2. Mansour-Ghanaei F, Mehrdad M, Mortazavi S, Joukar F, Khak M, Atrkar-Roushan Z. Decreased serum total T3 level in hepatitis B and C related cirrhosis by severity of liver damage. Ann Hepatol. 2012; 11(5): 667-71[PubMed]
  • 3. Boursier J, Cesbron E, Tropet AL, Pilette C. Comparison and improvement of MELD and Child-Pugh score accuracies for the prediction of 6-month mortality in cirrhotic patients. J Clin Gastroenterol. 2009; 43(6): 580-5[DOI][PubMed]
  • 4. Child CG. [Remote Results of Portal Surgery in Liver Cirrhosis]. Rev Int Hepatol. 1964; 14: 287-8[PubMed]
  • 5. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973; 60(8): 646-9[PubMed]
  • 6. Wehler M, Kokoska J, Reulbach U, Hahn EG, Strauss R. Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems. Hepatology. 2001; 34(2): 255-61[DOI][PubMed]
  • 7. Campbell DP, Parker DE, Anagnostopoulos CE. Survival prediction in portacaval shunts: a computerized statistical analysis. Am J Surg. 1973; 126(6): 748-51[PubMed]
  • 8. Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg. 1964; 1: 1-85[PubMed]
  • 9. Freeman RB, Jr., Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl. 2002; 8(9): 851-8[DOI][PubMed]
  • 10. Wiesner RH, Edwards E, Freeman R, Harper A. Does the model for end-stage liver disease (MELD) predict post liver transplant graft survival? Hepat. 2003; 38(4): 370a-1a
  • 11. Onaca NN, Levy MF, Sanchez EQ, Chinnakotla S, Fasola CG, Thomas MJ, et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl. 2003; 9(2): 117-23[DOI][PubMed]
  • 12. Saab S, Wang V, Ibrahim AB, Durazo F, Han S, Farmer DG, et al. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl. 2003; 9(5): 473-6[DOI][PubMed]
  • 13. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001; 33(2): 464-70[DOI][PubMed]
  • 14. Mendez-Sanchez N, Almeda-Valdes P, Uribe M. Alcoholic liver disease. An update. Ann Hepatol. 2005; 4(1): 32-42[PubMed]
  • 15. Huo TI, Lee SD, Lin HC. Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond. Liver Int. 2008; 28(5): 606-13[DOI][PubMed]
  • 16. Tsoulfas G, Agorastou P. Role of living donor liver transplantation in the treatment of hepatitis C virus infection. Hepat Mon. 2011; 11(6): 427-33[PubMed]
  • 17. Samada Suarez M, Hernandez Perera JC, Ramos Robaina L, Barroso Marquez L, Gonzalez Rapado L, Cepero Valdes M, et al. Factors that predict survival in patients with cirrhosis considered for liver transplantation. Transplant Proc. 2008; 40(9): 2965-7[DOI][PubMed]
  • 18. Kim YS, Um SH, Ryu HS, Lee JB, Lee JW, Park DK, et al. The prognosis of liver cirrhosis in recent years in Korea. J Korean Med Sci. 2003; 18(6): 833-41[PubMed]
  • 19. Olthoff KM, Brown RS, Jr., Delmonico FL, Freeman RB, McDiarmid SV, Merion RM, et al. Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA. Liver Transpl. 2004; 10(10 Suppl 2)-22[DOI][PubMed]
  • 20. Merion RM. When is a patient too well and when is a patient too sick for a liver transplant? Liver Transpl. 2004; 10(10 Suppl 2)-73[DOI][PubMed]
  • 21. Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol. 2005; 42 Suppl(1)-7[DOI][PubMed]
  • 22. Oberkofler CE, Dutkowski P, Stocker R, Schuepbach RA, Stover JF, Clavien PA, et al. Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients. Crit Care. 2010; 14(3)[DOI][PubMed]
  • 23. Orloff MJ, Vaida F, Isenberg JI, Wheeler HO, Haynes KS, Jinich-Brook H, et al. Child-Turcotte score versus MELD for prognosis in a randomized controlled trial of emergency treatment of bleeding esophageal varices in cirrhosis. J Surg Res. 2012; 178(1): 139-46[DOI][PubMed]
  • 24. Craig DG, Reid TW, Wright EC, Martin KG, Davidson JS, Hayes PC, et al. The sequential organ failure assessment (SOFA) score is prognostically superior to the model for end-stage liver disease (MELD) and MELD variants following paracetamol (acetaminophen) overdose. Aliment Pharmacol Ther. 2012; 35(6): 705-13[DOI][PubMed]
  • 25. Mukerji AN, Patel V, Jain A. Improving survival in decompensated cirrhosis. Int J Hepatol. 2012; 2012: 318627[DOI][PubMed]
  • 26. Ghadir MR, Riahin AA, Havaspour A, Nooranipour M, Habibinejad AA. The relationship between lipid profile and severity of liver damage in cirrhotic patients. Hepat Mon. 2010; 10(4): 285-8[PubMed]
  • 27. Ahn J, Cohen SM. Prevention of hepatitis B recurrence in liver transplant patients using oral antiviral therapy without long-term hepatitis B immunoglobulin. Hepat Mon. 2011; 11(8): 638-45[PubMed]
  • 28. Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R. Results of the first year of the new liver allocation plan. Liver Transpl. 2004; 10(1): 7-15[DOI][PubMed]
  • 29. Saberifiroozi M, Serati AR, Malekhosseini SA, Salahi H, Bahador A, Lankarani KB, et al. Analysis of patients listed for liver transplantation in Shiraz, Iran. Indian J Gastroenterol. 2006; 25(1): 11-3[PubMed]
  • 30. Ghods AJ, Mahdavi M. Organ transplantation in Iran. Saudi J Kidney Dis Transpl. 2007; 18(4): 648-55[PubMed]
  • 31. Mahmoudi H, Jafari P, Alizadeh-Naini M, Gholami S, Malek-Hosseini SA, Ghaffaripour S. Validity and reliability of Persian version of Chronic Liver Disease Questionnaire (CLDQ). Qual Life Res. 2012; 21(8): 1479-85[DOI][PubMed]
  • 32. Lankarani KB, Mahmoodi M, Gholami S, Mehravar S, Malekhosseini SA, Heydari ST, et al. Reducing Social Disparity in Liver Transplantation Utilization through Governmental Financial Support. Hepat Mon. 2012; 12(11)[DOI][PubMed]
  • 33. Klein JP, Moeschberger ML. Survival analysis: techniques for censored and truncated data. 2003;
  • 34. Heuman DM, Mihas AA, Habib A, Gilles HS, Stravitz RT, Sanyal AJ, et al. MELD-XI: a rational approach to "sickest first" liver transplantation in cirrhotic patients requiring anticoagulant therapy. Liver Transpl. 2007; 13(1): 30-7[DOI][PubMed]
  • 35. Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000; 56(2): 337-44[PubMed]
  • 36. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982; 143(1): 29-36[PubMed]
  • 37. Heagerty PJ, Zheng Y. Survival model predictive accuracy and ROC curves. Biometrics. 2005; 61(1): 92-105[DOI][PubMed]
  • 38. Cai CJ, Chen HA, Lu MQ, Chen GH. Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B. Chin Med J (Engl). 2008; 121(20): 2065-9[PubMed]
  • 39. Cuomo O, Perrella A, Arenga G. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system? Transplant Proc. 2008; 40(6): 1906-9[DOI][PubMed]
  • 40. Sumskiene J, Kupcinskas L, Pundzius J, Sumskas L. Prognostic factors for short and long-term survival in patients selected for liver transplantation. Medicina (Kaunas). 2005; 41(1): 39-46[PubMed]
  • 41. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000; 31(4): 864-71[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments